SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

<p><strong>Background</strong> Most studies of immunity to SARS-CoV-2 focus on circulating antibody, giving limited insights into mucosal defences that prevent viral replication and onward transmission. We studied nasal and plasma antibody responses one year after hospitalisation f...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Liew, F, Talwar, S, Cross, A, Willett, BJ, Scott, S, Logan, N, Siggins, MK, Swieboda, D, Sidhu, JK, Efstathiou, C, Moore, SC, Davis, C, Mohamed, N, Nunag, J, King, C, Thompson, AAR, Rowland-Jones, SL, Docherty, AB, Chalmers, JD, Ho, L-P, Horsley, A, Raman, B, Poinasamy, K, Marks, M, Kon, OM, Howard, L, Wootton, DG, Dunachie, S, Quint, JK, Evans, RA, Wain, LV, Fontanella, S, de Silva, TI, Ho, A, Harrison, E, Baillie, JK, Semple, MG, Brightling, C, Thwaites, RS, Turtle, L, Openshaw, PJM
Weitere Verfasser: ISARIC4C Investigators
Format: Journal article
Sprache:English
Veröffentlicht: Elsevier 2022

Ähnliche Einträge

Ähnliche Einträge